Patent details

EP1438957 Title: Raloxifene in the treatment of postmenopausal osteoporosis

Basic Information

Publication number:
EP1438957
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP041016155
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Raloxifene in the treatment of postmenopausal osteoporosis
French Title of Invention:
Raloxifène destinée au traitement de l'ostéoporose post-ménopause
German Title of Invention:
Raloxifene in der Behandlung von postmeopausal Osteoporose
SPC Number:

Dates

Filing date:
26/07/1993
Grant date:
11/04/2007
EP Publication Date:
11/04/2007
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2004
EP B1 Publication Date:
11/04/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/07/2013
Renunciation date:
Revocation date:
23/10/2012
Annulment date:

Owner

From:
26/07/1993
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/04/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Cullinan George Joseph
Address:
United States (US)

2

Name:
Black Larry John
Address:
United States (US)

Priority

Priority Number:
920933
Priority Date:
28/07/1992
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4535;
Filing date Document type Number of pages